Martin Purtscher

4.6k total citations · 2 hit papers
21 papers, 3.9k citations indexed

About

Martin Purtscher is a scholar working on Virology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Martin Purtscher has authored 21 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Martin Purtscher's work include HIV Research and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Protein purification and stability (5 papers). Martin Purtscher is often cited by papers focused on HIV Research and Treatment (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Protein purification and stability (5 papers). Martin Purtscher collaborates with scholars based in Austria, United States and Slovakia. Martin Purtscher's co-authors include Alexandra Trkola, H. Katinger, Franz Steindl, Thomas Muster, Andrea Buchacher, A. Klima, Florian Rüker, Gottfried Himmler, Hermann Katinger and John P. Moore and has published in prestigious journals such as Blood, Journal of Virology and Journal of Chromatography A.

In The Last Decade

Martin Purtscher

20 papers receiving 3.8k citations

Hit Papers

Human monoclonal antibody 2G12 defines a distinctive neut... 1993 2026 2004 2015 1996 1993 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
    1996 925 citations Alexandra Trkola, Martin Purtscher et al. Journal of Virology profile →
  2. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
    1993 850 citations Thomas Muster, Franz Steindl et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Purtscher Austria 17 3.1k 1.8k 1.3k 1.2k 1.1k 21 3.9k
Franz Steindl Austria 19 2.4k 0.8× 1.5k 0.9× 1.1k 0.8× 993 0.9× 862 0.8× 41 3.1k
Victoria R. Polonis United States 33 3.5k 1.1× 1.9k 1.0× 651 0.5× 972 0.8× 1.6k 1.4× 89 4.3k
Ann J. Hessell United States 25 3.4k 1.1× 2.5k 1.4× 1.3k 1.0× 1.2k 1.0× 1.6k 1.4× 63 5.0k
Gary Landucci United States 24 2.2k 0.7× 2.1k 1.1× 910 0.7× 764 0.7× 655 0.6× 50 3.3k
Stephen R. Petteway United States 25 3.1k 1.0× 1.4k 0.8× 452 0.3× 1.6k 1.4× 2.1k 1.8× 47 4.8k
Nicole A. Doria‐Rose United States 29 2.3k 0.7× 1.5k 0.8× 818 0.6× 946 0.8× 924 0.8× 68 3.0k
Gunilla B. Karlsson Hedestam Sweden 37 1.2k 0.4× 2.1k 1.2× 602 0.5× 1.2k 1.0× 1.1k 0.9× 113 4.0k
Celia C. LaBranche United States 33 2.8k 0.9× 1.8k 1.0× 629 0.5× 1.2k 1.0× 1.3k 1.1× 149 3.9k
Constance Williams United States 28 2.3k 0.7× 1.3k 0.7× 904 0.7× 658 0.6× 933 0.8× 47 2.6k
George B. Thornton United States 24 908 0.3× 1.3k 0.7× 735 0.6× 890 0.8× 639 0.6× 38 3.2k

Countries citing papers authored by Martin Purtscher

Since Specialization
Citations

This map shows the geographic impact of Martin Purtscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Purtscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Purtscher more than expected).

Fields of papers citing papers by Martin Purtscher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Purtscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Purtscher. The network helps show where Martin Purtscher may publish in the future.

Co-authorship network of co-authors of Martin Purtscher

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Purtscher. A scholar is included among the top collaborators of Martin Purtscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Purtscher. Martin Purtscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fiedler, Christian, et al.. (2023). On-column virus inactivation by solvent/detergent treatment for a recombinant biological product. Biologicals. 83. 101693–101693. 2 indexed citations
2.
Turecek, Peter L., M.J. Bossard, Michael Graninger, et al.. (2012). BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.. PubMed. 32 Suppl 1. S29–38. 86 indexed citations
3.
Siekmann, Jürgen, Martin Purtscher, Hanspeter Rottensteiner, et al.. (2011). Development of a Large Scale Production Process for BAX 855, a PEGylated rFVIII Product with Prolonged Half-Life. Blood. 118(21). 4362–4362. 1 indexed citations
4.
Turecek, Peter L., Artur Mitterer, Herbert Gritsch, et al.. (2009). Development of a plasma- and albumin -free recombinant von Willebrand factor. Hämostaseologie. 29(S 01). S32–S38. 49 indexed citations
5.
Turecek, Peter L., Artur Mitterer, Herbert Gritsch, et al.. (2006). Biochemical and Functional Characterization of a Serum-Free rVWF Drug Candidate.. Blood. 108(11). 1017–1017. 2 indexed citations
6.
Semlitsch, Thomas, Neven Žarković, Suzana Borović, et al.. (2002). Differential influence of the lipid peroxidation product 4-hydroxynonenal on the growth of human lymphatic leukaemia cells and human periopherial blood lymphocytes.. PubMed. 22(3). 1689–97. 23 indexed citations
7.
Stiegler, Gabriela, Renate Kunert, Martin Purtscher, et al.. (2001). A Potent Cross-Clade Neutralizing Human Monoclonal Antibody against a Novel Epitope on gp41 of Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 17(18). 1757–1765. 411 indexed citations
8.
Kunert, Renate, et al.. (2000). Stable recombinant expression of the anti HIV-1 monoclonal antibody 2F5 after IgG3/IgG1 subclass switch in CHO cells. Biotechnology and Bioengineering. 67(1). 97–103. 51 indexed citations
9.
Steindl, Franz, Christine Armbruster, Karen Pierer, Martin Purtscher, & Hermann Katinger. (1998). A simple and robust method for the complete dissociation of HIV-1 p24 and other antigens from immune complexes in serum and plasma samples. Journal of Immunological Methods. 217(1-2). 143–151. 29 indexed citations
10.
Purtscher, Martin, Alexandra Trkola, Andreas Grassauer, et al.. (1996). Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5. AIDS. 10(6). 587–594. 142 indexed citations
11.
Eckhart, Leopold, Wolfgang Raffelsberger, Boris Ferko, et al.. (1996). Immunogenic Presentation of a Conserved gp41 Epitope of Human Immunodeficiency Virus Type 1 on Recombinant Surface Antigen of Hepatitis B Virus. Journal of General Virology. 77(9). 2001–2008. 97 indexed citations
12.
Trkola, Alexandra, Martin Purtscher, Thomas Muster, et al.. (1996). Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. Journal of Virology. 70(2). 1100–1108. 925 indexed citations breakdown →
13.
Muster, Thomas, Boris Ferko, A. Klima, et al.. (1995). Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. Journal of Virology. 69(11). 6678–6686. 93 indexed citations
14.
Buchacher, Andrea, K. Strutzenberger, W. Steinfellner, et al.. (1994). Generation of Human Monoclonal Antibodies against HIV-1 Proteins; Electrofusion and Epstein-Barr Virus Transformation for Peripheral Blood Lymphocyte Immortalization. AIDS Research and Human Retroviruses. 10(4). 359–369. 439 indexed citations
15.
Purtscher, Martin, Alexandra Trkola, Gerhard Grüber, et al.. (1994). A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1. AIDS Research and Human Retroviruses. 10(12). 1651–1658. 299 indexed citations
16.
Muster, Thomas, Rosario Guinea, Alexandra Trkola, et al.. (1994). Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. Journal of Virology. 68(6). 4031–4034. 237 indexed citations
17.
Muster, Thomas, Franz Steindl, Martin Purtscher, et al.. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology. 67(11). 6642–6647. 850 indexed citations breakdown →
18.
Jungbauer, Alois, Christa Tauer, Karola Vorauer‐Uhl, et al.. (1990). Isolation of isoproteins from monoclonal antibodies and recombinant proteisn by chromatofocusing. Journal of Chromatography A. 512. 157–163. 16 indexed citations
19.
Jungbauer, Alois, Christa Tauer, Elisabeth Wenisch, et al.. (1989). Pilot scale production of a human monoclonal antibody against human immunodeficiency virus HIV-1. Journal of Biochemical and Biophysical Methods. 19(2-3). 223–240. 23 indexed citations
20.
Tauer, Christa, Manfred Reiter, Martin Purtscher, et al.. (1989). Comparison of protein A, protein G and copolymerized hydroxyapatite for the purification of human monoclonal antibodies. Journal of Chromatography A. 476. 257–268. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz Steindl Breakdown of academic impact, for papers by Victoria R. Polonis Breakdown of academic impact, for papers by Ann J. Hessell Breakdown of academic impact, for papers by Gary Landucci Breakdown of academic impact, for papers by Stephen R. Petteway Breakdown of academic impact, for papers by Nicole A. Doria‐Rose Breakdown of academic impact, for papers by Gunilla B. Karlsson Hedestam Breakdown of academic impact, for papers by Celia C. LaBranche Breakdown of academic impact, for papers by Constance Williams Breakdown of academic impact, for papers by George B. Thornton
Rankless by CCL
2026